Novavax
NVAX
#4816
Rank
HK$16.50 B
Marketcap
HK$100.05
Share price
15.80%
Change (1 day)
54.34%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of June 2026 : -HK$1.5 Billion

According to Novavax's latest financial reports the company has -HK$1.5 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-HK$1 Billion-79.48%
2024-12-31$-HK$4.85 Billion-13.5%
2023-12-31$-HK$5.6 Billion13.02%
2022-12-31$-HK$4.96 Billion80.67%
2021-12-31$-HK$2.75 Billion-156.4%
2020-12-31$HK$4.86 B-435.62%
2019-12-31$-HK$1.45 Billion10.16%
2018-12-31$-HK$1.32 Billion65.46%
2017-12-31$-HK$0.8 Billion1748.15%
2016-12-31$-HK$43.01 Million-101.9%
2015-12-31$HK$2.26 B27.36%
2014-12-31$HK$1.78 B13.01%
2013-12-31$HK$1.57 B153.39%
2012-12-31$HK$0.62 B48.71%
2011-12-31$HK$0.41 B-8.99%
2010-12-31$HK$0.45 B-15.27%
2009-12-31$HK$0.54 B54.3%
2008-12-31$HK$0.35 B-28.51%
2007-12-31$HK$0.49 B-32.74%
2006-12-31$HK$0.73 B89.91%
2005-12-31$HK$0.38 B48.85%
2004-12-31$HK$0.25 B-7.17%
2003-12-31$HK$0.27 B342.54%
2002-12-31$HK$62.95 M-70.63%
2001-12-31$HK$0.21 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
HK$329.15 B-22,095.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$670.87 B-44,928.98%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$395.26 B-26,512.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$178.60 B-12,034.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$11.98 B-901.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$5.60 B-474.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-HK$1.62 Billion 7.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$71.83 M-104.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$3.57 Billion 138.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$2.67 B-279.02%๐Ÿ‡บ๐Ÿ‡ธ USA